The US Centers for Disease Control and Prevention (CDC) has stated that the United States has administered 405,444,558 doses of COVID-19 vaccines as of Thursday morning and distributed 490,951,045 doses, Reuters news agency reported on Friday.
This is an increase over 404,371,247 COVID-19 vaccines administered by Wednesday, out of 489,254,145 doses delivered.
According to the CDC, 217,953,275 people had received at least one COVID-19 vaccine dose, while 188,281,747 people are fully vaccinated as Thursday morning.
This tally includes two-dose vaccines from Moderna (Nasdaq:MRNA) and Pfizer (NYSE:PFE)/BioNTech (Nasdaq:BNTX), as well as Johnson & Johnson's (NYSE:JNJ) one-shot vaccine.
Also, over 9.3 million people have received a booster dose of either the Pfizer or Moderna vaccine since 13 August 2021, when the US authorised a third dose of COVID-19 vaccines for people with compromised immune systems who are likely to have weaker protection from two doses.
Clover Bio announces SCB-1019 vaccine candidate Phase I trial data in initial young adult cohort
Sanofi launches Verorab for rabies prophylaxis in UK
BioVaxys expands patent portfolio for DPX delivery platform and advances DPX SurMAGE
VGXI names new chief accounting officer
Moderna reports positive interim results from next-generation COVID-19 vaccine trial
Valneva launches Phase 1 trial for next-generation Zika vaccine
Circio Holding ASA confirms licensing deal with IOVaxis Therapeutics in China and Singapore
Everest Medicines names new chief medical officer and chief product officer
Pfizer's PREVENAR 20 gains European Commission approval for paediatric pneumococcal vaccine
Virbac expands presence in Japan with Sasaeah acquisition
Pfizer reveals strong efficacy data for ABRYSVO in older adults against RSV